Lessons learned from the polio eradication initiative in the Democratic Republic of Congo and Ethiopia: analysis of implementation barriers and strategies.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
18 Dec 2020
Historique:
received: 10 11 2020
accepted: 11 11 2020
entrez: 19 12 2020
pubmed: 20 12 2020
medline: 17 3 2021
Statut: epublish

Résumé

Since its inception in 1988, the Global Polio Eradication Initiative (GPEI) has partnered with 200 countries to vaccinate over 2.5 billion children against poliomyelitis. The polio eradication approach has adapted to emerging challenges and diverse contexts. Knowledge assets gained from these experiences can inform implementation of future health programs, but only if efforts are made to systematically map barriers, identify strategies to overcome them, identify unintended consequences, and compare experiences across country contexts. A sequential explanatory mixed methods design, including an online survey followed by key informant interviews (KIIs), was utilized to map tacit knowledge derived from the polio eradication experience from 1988 to 2019. The survey and KIIs were conducted between September 2018 and March 2019. A cross-case comparison was conducted of two study countries, the Democratic Republic of Congo (DRC) and Ethiopia, which fit similar epidemiological profiles for polio. The variables of interest (implementation barriers, strategies, unintended consequences) were compared for consistencies and inconsistencies within and across the two country cases. Surveys were conducted with 499 and 101 respondents, followed by 23 and 30 KIIs in the DRC and Ethiopia, respectively. Common implementation barriers included accessibility issues caused by political insecurity, population movement, and geography; gaps in human resources, supply chain, finance and governance; and community hesitancy. Strategies for addressing these barriers included adapting service delivery approaches, investing in health systems capacity, establishing mechanisms for planning and accountability, and social mobilization. These investments improved system infrastructure and service delivery; however, resources were often focused on the polio program rather than strengthening routine services, causing community mistrust and limiting sustainability. The polio program investments in the DRC and Ethiopia facilitated program implementation despite environmental, system, and community-level barriers. There were, however, missed opportunities for integration. Remaining pockets of low immunization coverage and gaps in surveillance must be addressed in order to prevent importation of wild poliovirus and minimize circulating vaccine-derived poliovirus. Studying these implementation processes is critical for informing future health programs, including identifying implementation tools, strategies, and principles which can be adopted from polio eradication to ensure health service delivery among hard-to-reach populations. Future disease control or eradication programs should also consider strategies which reduce parallel structures and define a clear transition strategy to limit long-term external dependency.

Sections du résumé

BACKGROUND BACKGROUND
Since its inception in 1988, the Global Polio Eradication Initiative (GPEI) has partnered with 200 countries to vaccinate over 2.5 billion children against poliomyelitis. The polio eradication approach has adapted to emerging challenges and diverse contexts. Knowledge assets gained from these experiences can inform implementation of future health programs, but only if efforts are made to systematically map barriers, identify strategies to overcome them, identify unintended consequences, and compare experiences across country contexts.
METHODS METHODS
A sequential explanatory mixed methods design, including an online survey followed by key informant interviews (KIIs), was utilized to map tacit knowledge derived from the polio eradication experience from 1988 to 2019. The survey and KIIs were conducted between September 2018 and March 2019. A cross-case comparison was conducted of two study countries, the Democratic Republic of Congo (DRC) and Ethiopia, which fit similar epidemiological profiles for polio. The variables of interest (implementation barriers, strategies, unintended consequences) were compared for consistencies and inconsistencies within and across the two country cases.
RESULTS RESULTS
Surveys were conducted with 499 and 101 respondents, followed by 23 and 30 KIIs in the DRC and Ethiopia, respectively. Common implementation barriers included accessibility issues caused by political insecurity, population movement, and geography; gaps in human resources, supply chain, finance and governance; and community hesitancy. Strategies for addressing these barriers included adapting service delivery approaches, investing in health systems capacity, establishing mechanisms for planning and accountability, and social mobilization. These investments improved system infrastructure and service delivery; however, resources were often focused on the polio program rather than strengthening routine services, causing community mistrust and limiting sustainability.
CONCLUSIONS CONCLUSIONS
The polio program investments in the DRC and Ethiopia facilitated program implementation despite environmental, system, and community-level barriers. There were, however, missed opportunities for integration. Remaining pockets of low immunization coverage and gaps in surveillance must be addressed in order to prevent importation of wild poliovirus and minimize circulating vaccine-derived poliovirus. Studying these implementation processes is critical for informing future health programs, including identifying implementation tools, strategies, and principles which can be adopted from polio eradication to ensure health service delivery among hard-to-reach populations. Future disease control or eradication programs should also consider strategies which reduce parallel structures and define a clear transition strategy to limit long-term external dependency.

Identifiants

pubmed: 33339529
doi: 10.1186/s12889-020-09879-9
pii: 10.1186/s12889-020-09879-9
pmc: PMC7747367
doi:

Substances chimiques

Poliovirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1807

Subventions

Organisme : Bill and Melinda Gates Foundation
ID : OPP1178578

Références

MMWR Morb Mortal Wkly Rep. 2019 Mar 08;68(9):225-230
pubmed: 30845121
Vaccine. 2016 Oct 10;34(43):5164-5169
pubmed: 27646028
Implement Sci. 2012 Mar 20;7:20
pubmed: 22433980
Vaccine. 2016 Oct 10;34(43):5175-5180
pubmed: 27378681
J Infect Dis. 2014 Nov 1;210 Suppl 1:S504-13
pubmed: 24690667
PLoS One. 2019 May 24;14(5):e0217426
pubmed: 31125375
Vaccine. 2017 Oct 9;35(42):5693-5699
pubmed: 28882442
Vaccine. 2016 Oct 10;34(43):5150-5154
pubmed: 27395564
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
BMC Public Health. 2020 Aug 12;20(Suppl 2):1197
pubmed: 32787958
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
BMC Public Health. 2020 Aug 12;20(Suppl 2):1176
pubmed: 32787949
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226

Auteurs

Wakgari Deressa (W)

School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.

Patrick Kayembe (P)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.

Abigail H Neel (AH)

International Health Department, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD, 21205, USA. aneel1@jhu.edu.

Eric Mafuta (E)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.

Assefa Seme (A)

School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.

Olakunle Alonge (O)

International Health Department, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD, 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH